Joel Greenblatt’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Buy
465,714
+134,682
+41% +$3.11M 0.03% 760
2026
Q1
$7.92M Buy
331,032
+181,926
+122% +$4.45M 0.02% 749
2025
Q4
$3.37M Buy
149,106
+37,202
+33% +$810K 0.01% 903
2025
Q3
$2.25M Sell
111,904
-13,090
-10% -$219K 0.01% 968
2025
Q2
$1.78M Sell
124,994
-230,212
-65% -$2.69M 0.01% 960
2025
Q1
$3.73M Sell
355,206
-122,562
-26% -$1.39M 0.03% 607
2024
Q4
$5.79M Buy
477,768
+138,812
+41% +$1.82M 0.05% 478
2024
Q3
$4.98M Buy
338,956
+178,383
+111% +$2.49M 0.05% 489
2024
Q2
$2.32M Buy
+160,573
New +$2.57M 0.03% 643
2023
Q1
Sell
-234,126
Closed -$2.86M 1342
2022
Q4
$2.86M Buy
234,126
+10,320
+5% +$129K 0.08% 312
2022
Q3
$2.78M Buy
+223,806
New +$3.91M 0.08% 296
2022
Q2
Sell
-129,175
Closed -$3.37M 1156
2022
Q1
$3.37M Buy
129,175
+77,091
+148% +$2.05M 0.1% 244
2021
Q4
$1.48M Buy
+52,084
New +$1.62M 0.05% 439
2020
Q4
Sell
-101,060
Closed -$2.82M 1027
2020
Q3
$2.82M Buy
101,060
+89,372
+765% +$2.26M 0.09% 290
2020
Q2
$251K Buy
+11,688
New +$258K 0.01% 905

Other funds holding ELAN

Joel Greenblatt's ELAN Position: Q2 2026 in Review

Joel Greenblatt increased its Elanco Animal Health (ELAN) stake by 41% in Q2 2026, buying an estimated $3.11M and bringing the position to 465,714 shares worth $11.5M. The position accounts for 0.03% of the portfolio, ranked #760.

Joel Greenblatt first reported a position in ELAN in Q2 2020 and has held it in 15 quarters since. 517 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Joel Greenblatt held 465,714 shares of Elanco Animal Health worth $11.5M as of Q2 2026.
  • Joel Greenblatt bought 134,682 Elanco Animal Health shares in Q2 2026, an estimated $3.11M.
  • Elanco Animal Health made up 0.03% of Joel Greenblatt's portfolio in Q2 2026, its #760 holding.
  • Joel Greenblatt first reported a position in Elanco Animal Health in Q2 2020 and has held it in 15 quarters since.
  • 517 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.